Patents by Inventor Frederic Maxime VAZ

Frederic Maxime VAZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios
    Patent number: 11650212
    Abstract: The invention relates to a method of diagnosing or screening for 27-hydroxylase (CYP27A1) deficiency in an animal comprising: determining in a biological sample the intensity signal by mass analysis of at least a bile alcohol glucuronide and a C24- or C27-bile acid or a conjugate thereof, comparing the intensity signals to a control sample or control value, and determining 27-hydroxylase (CYP27A1) deficiency based on said comparison.
    Type: Grant
    Filed: March 4, 2018
    Date of Patent: May 16, 2023
    Assignee: Academisch Medisch Centrum
    Inventor: Frederic Maxime Vaz
  • A SCREENING METHOD FOR CEREBROTENDINOUS XANTHOMATOSIS USING BILE ALCOHOL GLUCURONIDES AND METABOLITE RATIOS
    Publication number: 20210033626
    Abstract: The invention relates to a method of diagnosing or screening for 27-hydroxylase (CYP27A1) deficiency in an animal comprising: determining in a biological sample the intensity signal by mass analysis of at least a bile alcohol glucuronide and a C24- or C27-bile acid or a conjugate thereof, comparing the intensity signals to a control sample or control value, and determining 27-hydroxylase (CYP27A1) deficiency based on said comparison.
    Type: Application
    Filed: March 4, 2018
    Publication date: February 4, 2021
    Inventor: Frederic Maxime VAZ